One of the biggest obstacles to the use of custom antibodies in research is their cost. Although they fit like a glove to the needs of the researcher and the results tend to be more precise thanks to the high degree of specificity, the prices can be prohibitive for those in less well-funded research groups.

This high price is to be expected considering what goes behind the production of a custom antibody. The variable nature of the production protocol, adjusted to each specific case, makes the process less predictable and requires more attention and work by specialized personnel, as well as a greater consumption of materials.

However, this high cost may lead some researchers to have to resort to less specific antibodies for their experiments, or even to lines of research being discarded altogether.

What is the solution in those cases?

Standardized custom antibodies

The solution to this dilemma lies in the standardization of polyclonal antibody production and purification processes in order to reduce costs without losing the specificity of a custom-designed molecule.

Abyntek Biopharma has designed a protocol that, if carried out without modification, guarantees the production of a custom polyclonal antibody with a minimum titer of 30,000 at a reduced cost.

The idea arises from analysing the needs of some customers. They required a personalized antibody, either because the commercial options did not work well or because there was nothing on the market that met their needs. However, many of these research groups did not have the necessary budget to finance the production of a custom antibody.

That is why we have combined the know-how of our technical team with a highly optimized experimental design to reduce variability and the need for a highly specialized professional, thus reducing the cost.

Standardized custom antibodies

The solution to this dilemma lies in the standardization of polyclonal antibody production and purification processes in order to reduce costs without losing the specificity of a custom-designed molecule.

Abyntek Biopharma has designed a protocol that, if carried out without modification, guarantees the production of a custom polyclonal antibody with a minimum titer of 30,000 at a reduced cost.

The idea arises from analysing the needs of some customers. They required a personalized antibody, either because the commercial options did not work well or because there was nothing on the market that met their needs. However, many of these research groups did not have the necessary budget to finance the production of a custom antibody.

That is why we have combined the know-how of our technical team with a highly optimized experimental design to reduce variability and the need for a highly specialized professional, thus reducing the cost.

Launching offer

Thanks to the standardization of the process, the production of these standardized polyclonal antibodies is already considerably cheaper than most alternatives on the market.

The reduction in variability, both at the level of processes and materials, allows us to offer this service for only 1,999 euros. In addition, we make an introductory offer of 15% discount available to Spanish researchers to make testing this service even easier.Check the details of the offer here and contact us to request your standardized polyclonal antibodies.

Pin It on Pinterest

Share This